跳至主要内容
临床试验/NCT00886080
NCT00886080已完成不适用

A Prospective Randomised Multicentre Comparison on Health Related Quality of Life: the Value of Add-on Arrhythmia Surgery in Patients With Atrial Fibrillation Undergoing Valvular and/or Coronary Bypass Surgery

Maastricht University Medical Center1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2002年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
Quality of life and maintenance of sinus rhythm at 1 year will be considered as primary end points.

研究概览

简要总结

Atrial fibrillation (AF) is connected with an increased morbidity and mortality. In addition, quality of life is diminished due to palpitations, dyspnea, dizziness and syncope. AF is frequently associated with valvular and coronary disease. In the AF patients undergoing valvular or coronary surgery the arrhythmia almost always relapses. For symptom control anti-arrhythmic drugs and cardioversion are used but breakthrough arrhythmias and side effects of the drugs happen frequently. For more effective symptom control "add-on" arrhythmia surgery is being advocated. However, at present the investigators do not know whether add-on arrhythmia surgery indeed affects morbidity and quality of life.

The hypothesis being studied is that add-on arrhythmia surgery in patients with AF undergoing valvular or coronary surgery improves quality of life, establishes chronic sinus rhythm and reduces perioperative and long-term morbidity associated with AF.

详细描述

Multicentre prospective parallel randomised controlled trial. In total 150 patients with documented atrial fibrillation (chronic and paroxysmal), were randomly assigned by a central computer system to undergo cardiac surgery with add-on surgery or without. This assignment was blinded to patients and all medical personnel except for the surgical team during total follow up. Patients completed quality of life questionnaires, comprising the RAND 36-item Health Survey 1.0 (SF-36), Multidimensional Fatigue Inventory-20 (MFI-20) and EuroQoL (EQ-5D and VAS) at baseline and 3, 6 and 12 months following operation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Patients undergo valvular surgery and/ or coronary surgery,
  • •All patients have documented chronic atrial fibrillation of paroxysmal atrial fibrillation.
  • •Patients have given written informed consent.

排除标准

  • •Patients who do not speak Dutch or can not read Dutch.
  • •Patients with a Sick Sinus Syndrome.
  • •Patients with contraindications for oral anticoagulant agents.
  • •Incompetent to act for oneself

研究组 & 干预措施

Add-on arrhythmia surgery

Experimental

Adjuvant anti-arrhythmic surgery consists of a beating heart epicardial "box" isolation of all pulmonary veins using microwave energy (Flex 4 or Flex 10 ablation probes and Microwave generator by Guidant/Afix, Fremont, CA, USA). The surgical ablation procedure is the first step during surgery and is performed before institution of cardiopulmonary bypass allowing off-pump beating heart ablation. In addition excision or exclusion of the left atrial appendage is performed in both the treated as the control group.

干预措施: Pulmonary vein isolation using microwave energy (Procedure)

结局指标

主要结局

Quality of life and maintenance of sinus rhythm at 1 year will be considered as primary end points.

时间窗: Baseline, 3, 6, and 12 months after operation

次要结局

  • In-hospital and out-of-hospital morbidity and mortality during one year follow-up(Baseline, 1, 6 and 12 months after operation)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验